农场动物药品市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00005797
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 240
Buy Now

农畜药品市场预计将从2021年的182.5309亿美元增长到2028年的283.6408亿美元;预计 2021 年至 2028 年复合年增长率为 6.5%。

药物在维持农场动物的健康和改善农民的经济状况方面发挥着关键作用。农场生产者。随着人们寻求有营养且无疾病的食品,对更高生产力的需求变得更加重要。药理活性化合物有助于防止疾病从动物传播给人类。药物的使用极大地影响了农场动物的健康。农场动物药物是用于医疗保健实践的药物,用于诊断、治愈、缓解、治疗或预防可能影响牲畜的疾病。这些药物根据其维持农场动物健康的必要性按照严格要求使用。简而言之,农场动物药物是支持全球畜牧业发展的关键因素。农场动物止痛药物的使用不断增加、食源性疾病和感染发病率上升、对优质药品和粮食安全的需求激增等因素推动了农场动物药品市场的增长。然而,药物对动物的副作用以及与农场动物药物使用相关的严格政府规定阻碍了市场的增长。

战略见解
< br>

农场动物药物市场利润丰厚的区域



市场洞察

止痛药物的使用不断增加农场动物的疼痛促进了农场动物药物市场的增长

农场动物的疼痛通常与常见的生产疾病有关,例如跛行和乳腺炎,并通过常规饲养方式(例如阉割和断尾)传染给动物对接。疼痛会引起行为、自主神经和神经内分泌的变化;并诱发消极的情感状态,损害动物福利,损害农业盈利能力。

控制疼痛对于所有动物的健康至关重要。 2018 年,美国食品和药物管理局 (FDA) 批准了第一种用于食用动物的止痛药。腐蹄是所有年龄和品种的牛疼痛和跛行的常见原因。这种疾病常见于谷仓和塔内饲养的牛以及牧场上的牛。巴纳胺透皮药被批准用于治疗与牛腐蹄相关的疼痛,并且只能通过处方获得。 FDA 兽医中心通过确保为动物提供安全有效的药物来促进和保护动物健康。与制药公司合作开发和批准药物来控制所有动物(包括食用动物)的疼痛,是这一使命的一个组成部分。

动物有几种常规做法需要对动物进行有效疼痛管理的畜牧业。一些导致农场动物疼痛的常规程序包括阉割、去角或去芽。和品牌推广。用于控制农场动物疼痛的最常见药物包括非甾体类抗炎药(NSAID)、局部麻醉剂、α2-激动剂和阿片类药物。有效管理食用动物的疼痛已逐渐成为全世界消费者关注的问题,因此引起了监管机构的高度关注。因此,全球畜牧业正在不断发展新的做法和使用标签外镇痛药,同时考虑到动物福利和盈利能力。因此,这导致农场动物的一般疼痛管理实践中利多卡因、赛拉嗪、去托咪定、美托咪定、氯胺酮、托芬那酸、丁肾上腺素等镇痛药物的用量显着增加。

消费者越来越意识到并关心为食品而饲养的动物的福利。这给供应商带来了压力,要求他们确保进入其系统的动物受到人道对待。正在采取措施满足此类需求。在美国,只有一种药物被批准用于控制非哺乳牛的趾间蜂窝织炎(腐蹄)疼痛。因此,在选择性手术中使用药物来控制疼痛,例如牛的去角和去势,或泌乳奶牛和猪的镇痛,被认为是标签外药物的使用。根据《兽药使用法澄清》进行管理。氟尼辛、美洛昔康和酮洛芬是非甾体抗炎药,在农场镇痛方面有支持性研究。市场上有多种产品可以缓解动物的疼痛,例如局部麻醉剂、阿片类药物和非甾体抗炎药 (NSAID)。

产品基于类型的洞察

根据产品类型,农畜药品市场分为抗感染、杀寄生虫、抗炎、麻醉、镇痛、激素及相关产品等。寄生虫剂细分市场在 2021 年占据最大的市场份额,预计在预测期内复合年增长率最高。

农场动物药物市场,按产品类型划分 - 2021年和2028年


基于动物类型的见解

基于动物类型的农场动物药物市场分为牲畜和马。 2021 年,畜牧业占据最大市场份额,达到 90.77%,预计在预测期内将保持其主导地位。

基于管理的洞察路线< /h3>

根据给药途径,农畜药物市场分为口服、肠胃外、外用等。 2021年,口腔细分市场占据最大市场份额,达到90.77%,预计在预测期内将保持其主导地位。

基于分销渠道的洞察

根据分销渠道,农兽药市场分为兽医医院、兽医诊所、药店和药店等。兽医医院细分市场在 2021 年占据最大的市场份额,而兽医诊所细分市场的市场预计在预测期内将以 6.9% 的复合年增长率增长。

在农用动物药物市场上运营的各种公司正在采取产品发布、并购、合作、产品创新和产品组合扩展等策略,以扩大其在全球的足迹,维护品牌知名度,并满足最终用户不断增长的需求。

农畜药品市场——按产品类型

  • 抗感染剂
  • 杀寄生虫剂
  • 抗炎剂
  • 麻醉剂
  • 镇痛剂
  • 激素及相关产品
  • 其他

农畜药物市场 -按动物类型

  • 畜牧动物

农场动物药物市场 -按给药途径

  • 口服
  • 肠外给药
  • 外用
  • 其他

农场动物药品市场 –按分销渠道划分

  • 兽医医院
  • 兽医诊所
  • 药房和药店
  • 其他
  • 农场动物药物市场 –按地理

    •  北美

    • 美国
    • 加拿大
    • 墨西哥

    •  欧洲

    • 法国
    • 德国
    • 意大利
    • 英国
    • 西班牙
    • 欧洲其他地区

    •  亚太地区 (APAC)

    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳大利亚< /li>
    • 亚太地区其他地区

    •  中东及非洲 (MEA)

    • 南非
    • 沙特阿拉伯
    • 阿联酋
    • 中东其他地区和中东地区非洲

    •  南&中美洲 (SCAM)

    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

    公司简介

    • PHIBRO ANIMAL HEALTH CORPORATION
    • 硕腾公司
    • Ceva
    • Elanco< /li>
    • Virbac
    • INTAS PHARMACEUTICALS LTD.
    • Alembic Pharmaceuticals Limited
    • 勃林格殷格翰国际有限公司
    • 默沙东动物保健 < /li>
    • Vetoquinol SA
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is farm animal drug?

Drugs play a key role in maintaining the health of farm animals and improving the economic condition of farm producers. The need for better productivity has become important more, as the population are looking for nutritious and disease-free food products. The pharmacologically active compounds help prevent the passing of diseases from animals to humans. Farm animal’s health have been considerably shaped by the use of drugs. Farm animal drugs are medicines used for healthcare-based practices for diagnosis, cure, mitigation, treatment, or prevention of diseases that could affect livestock. These medicines are used as per strict requirements based on their essentiality to maintain the well-being of farm animals. Simply said, farm animal drugs are a key factor supporting the growth of the livestock industry across the world.

What are the driving factors for the farm animal drugs market across the globe?

Key factors that are driving the growth of this market are the growing use of pain management drugs in farm animals, rising incidence of foodborne diseases and infections, and surging demand for quality pharmaceuticals and food security are expected to boost the market growth for the farm animal drugs over the years.

Which product type led the farm animal drugs market?

The parasiticides segment dominated the global farm animal drugs market and held the largest revenue share of 26.88% in 2021.

Which animal type held the largest share in the farm animal drugs market?

The livestock animals segment dominated the global farm animal drugs market and accounted for the largest revenue share of 90.77% in 2021

Which route of administration held the largest share in the farm animal drugs market?

The oral segment dominated the global farm animal drugs market and accounted for the largest revenue share of 42.81% in 2021.

Which distribution channel held the largest share in the farm animal drugs market?

The veterinary hospitals segment dominated the global farm animal drugs market and accounted for the largest revenue share of 36.70% in 2021.

Who are the key players in the farm animal drugs market?

The farm animal drugs market majorly consists of the players such PHIBRO ANIMAL HEALTH CORPORATION, Zoetis Inc., Ceva, Elanco, Virbac, INTAS PHARMACEUTICALS LTD., Alembic Pharmaceuticals Limited, Boehringer Ingelheim International GmbH, MSD Animal Health, and Vetoquinol SA among others.

The List of Companies - Farm Animal Drugs Market

  1. PHIBRO ANIMAL HEALTH CORPORATION
  2. Zoetis Inc.
  3. Ceva
  4. Elanco
  5. Virbac
  6. INTAS PHARMACEUTICALS LTD.
  7. Alembic Pharmaceuticals Limited
  8. Boehringer Ingelheim International GmbH
  9. MSD Animal Health
  10. Vetoquinol SA

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports